Related Experiment Videos
Immunomodulation by cancer chemotherapeutic agents
1Department of Preclinical and Clinical Pharmacology, University of Florence, Firenze, Italy.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|December 1, 1987
Summary
Cytotoxic chemotherapy agents can impair or enhance immune functions, affecting cancer immunity. Understanding these complex drug effects is crucial for optimizing cancer treatment efficacy and reducing toxicity.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Cytotoxic agents impact cellular and humoral immunity, with potential to both impair and augment immune functions.
- These agents can alter tumor antigen expression, potentially increasing immunogenicity.
- Understanding these immunomodulatory effects is key to improving cancer therapy.
Purpose of the Study:
- To analyze the multifaceted effects of cytotoxic agents on the host immune system and tumor.
- To explore how different drug classes modulate immune responses in cancer patients.
- To provide insights for more rational application of chemotherapy regarding toxicity and efficacy.
Main Methods:
- Review of literature on the immunomodulatory effects of various cytotoxic agents.
- Analysis of drug-specific impacts on lymphocytes, NK cells, monocytes, and macrophages.
- Examination of effects on tumor antigenicity and host immune response.
Main Results:
- Glucocorticoids and antimetabolites (e.g., azathioprine, methotrexate) generally suppress immune functions.
- Cyclophosphamide shows dose-dependent effects, with high doses immunosuppressing and low doses immunostimulating.
- Cyclophosphamide's inhibition of T suppressor cells may be therapeutically significant; DX enhances lymphocyte proliferation and monocyte tumoricidal activity.
Conclusions:
- Cytotoxic agents exhibit complex immunomodulatory effects, influencing both host immunity and tumor characteristics.
- Differential effects on immune cells and functions necessitate careful consideration in treatment strategies.
- Further detailed studies are needed for optimizing the use of these agents in cancer chemotherapy.